Kristy Wonders
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.
Journal: Nature medicine
Published: December 11, 2025
The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLD.
Journal: JHEP reports : innovation in hepatology
Published: May 25, 2025
Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment.
Journal: Biochemical pharmacology
Published: January 22, 2024
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
Journal: Contemporary clinical trials
Published: May 30, 2023
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
Journal: The lancet. Gastroenterology & hepatology
Published: September 21, 2022
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.
Journal: Hepatology (Baltimore, Md.)
Published: June 16, 2022
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease.
Journal: Contemporary clinical trials
Published: May 25, 2020
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis.
Journal: Science translational medicine
Published: December 04, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026